Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Placebo-Controlled, Phase 2 Study of Docetaxel and Cisplatin/Carboplatin With or Without Erlotinib in Patients With Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck

NCT01064479 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.

NCT NCT01064479
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01064479 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Placebo-Controlled, Phase 2 Study of Docetaxel and Cisplatin/Carboplatin With or Without Erlotinib in Patients With Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck
Lead sponsor
M.D. Anderson Cancer Center
Phase
Phase 2
Overall status
Completed
Start date
February 5, 2010
Completion date
November 3, 2020
Enrollment
123 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic squamous cell carcinoma of the hypopharynx, metastatic squamous cell carcinoma of the larynx, metastatic squamous cell carcinoma of the oral cavity, metastatic squamous cell carcinoma of the oropharynx, recurrent hypopharyngeal squamous cell carcinoma, recurrent laryngeal squamous cell carcinoma, recurrent oral cavity squamous cell carcinoma, recurrent oropharyngeal squamous cell carcinoma, stage iv hypopharyngeal squamous cell carcinoma ajcc v7, stage iv laryngeal squamous cell carcinoma ajcc v7, stage iv oral cavity squamous cell carcinoma ajcc v6 and v7, stage iv oropharyngeal squamous cell carcinoma ajcc v7, stage iva hypopharyngeal squamous cell carcinoma ajcc v7, stage iva laryngeal squamous cell carcinoma ajcc v7, stage iva oral cavity squamous cell carcinoma ajcc v6 and v7, stage iva oropharyngeal squamous cell carcinoma ajcc v7, stage ivb hypopharyngeal squamous cell carcinoma ajcc v7, stage ivb laryngeal squamous cell carcinoma ajcc v7, stage ivb oral cavity squamous cell carcinoma ajcc v6 and v7, stage ivb oropharyngeal squamous cell carcinoma ajcc v7, stage ivc hypopharyngeal squamous cell carcinoma ajcc v7, stage ivc laryngeal squamous cell carcinoma ajcc v7, stage ivc oral cavity squamous cell carcinoma ajcc v6 and v7, stage ivc oropharyngeal squamous cell carcinoma ajcc v7